Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 440Lung Neoplasms 170Neoplasms 31Adenocarcinoma of Lung 27Neoplasm Metastasis 23Breast Neoplasms 23Prostatic Neoplasms 19Squamous Cell Carcinoma of Head and Neck 17Small Cell Lung Carcinoma 17Colorectal Neoplasms 13Melanoma 12Stomach Neoplasms 11Adenocarcinoma, Bronchiolo-Alveolar 11Pancreatic Neoplasms 10Ovarian Neoplasms 10Carcinoma, Renal Cell 10Head and Neck Neoplasms 9Urinary Bladder Neoplasms 8Recurrence 8Esthesioneuroblastoma, Olfactory 8Carcinoma, Squamous Cell 8Salivary Gland Neoplasms 7Esophageal Neoplasms 7NSCLC 6Carcinoma 6Advanced Non-Small Cell Lung Cancer 6Sarcoma 5Pleural Effusion, Malignant 5Parkinson Disease 4, Autosomal Dominant Lewy Body 5Carcinoma, Transitional Cell 5

Interventions

toripalimab 1pelcitoclax 1osimertinib 1Pemetrexed 1Paclitaxel 1Injections 1Erlotinib Hydrochloride 1Docetaxel 1Cisplatin 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
EGFR Positive Non-small Cell Lung Cancer × Docetaxel × Thoracic × Clear all
NCT06208033 2024-01-17

SMET12 and Toripalimab Combined Chemotherapy in Patients With EGFR Positive Advanced Non-small Cell Lung Cancer (NSCLC)

Fujian Cancer Hospital

Phase EARLY_PHASE1 Unknown
40 enrolled
Thoracic

EGFR Positive Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡